# ğŸ§  Early Prediction of Alzheimerâ€™s Disease Using Supervised Machine Learning Models

## ğŸ“Œ Project Description
This project aims to develop a **supervised Machine Learning model** capable of supporting the **early detection of Alzheimerâ€™s disease**, using clinical and demographic patient data.

The main objective is to build an **interpretable, clear, and socially impactful model**, suitable for a **basicâ€“intermediate level course**, while showcasing the full workflow of a data science project applied to healthcare.

---

## ğŸ¯ Problem Statement
Alzheimerâ€™s disease is a neurodegenerative condition that is often diagnosed at advanced stages, when cognitive decline is already significant.

This project seeks to:
- Support **early screening**
- Identify **risk patterns**
- Provide a **decision-support tool for healthcare professionals**
- Reduce false negatives by prioritizing **sensitivity (Recall)**

---

## ğŸ“Š Dataset
A public, tabular dataset related to Alzheimerâ€™s disease was used, containing clinical, functional, and cognitive patient information.

**Dataset characteristics:**
- Over 2,000 instances
- 35 clinical and demographic features
- Target variable: `Diagnosis`
  - `0` â†’ No Alzheimerâ€™s  
  - `1` â†’ Alzheimerâ€™s

---

## ğŸ§ª Most Relevant Features
After the feature selection process, the model identified the following variables as the most influential:

- **MMSE (Mini-Mental State Examination)**
- **ADL (Activities of Daily Living)**
- **Functional Assessment**
- Family history of Alzheimerâ€™s
- Depression
- Hypertension
- Difficulty completing tasks
- Confusion and disorientation

These features represent key dimensions of Alzheimerâ€™s disease:
- Cognition
- Functional capacity
- Independence
- Behavioral symptoms

---

## âš™ï¸ Methodology
The project follows a complete Machine Learning pipeline:

1. Exploratory Data Analysis (EDA)
2. Data cleaning and preprocessing
3. Correlation analysis
4. Feature selection
5. Class imbalance handling
6. Train/Test split
7. Standardization of numerical variables
8. Model training
9. Model evaluation using clinical metrics
10. Development of a graphical user interface

---

## ğŸ¤– Models Evaluated
Several supervised classification algorithms were tested:

- Logistic Regression
- K-Nearest Neighbors (KNN)
- Decision Tree
- Random Forest
- Support Vector Machine (SVM)
- Gaussian Naive Bayes
- **XGBoost (final selected model)**

ğŸ“Œ **XGBoost** achieved the best overall performance, particularly in **Recall**, which was the prioritized metric due to its clinical relevance.

---

## ğŸ“ˆ Evaluation Metrics
The following evaluation metrics were used:

- Accuracy
- Precision
- Recall (**primary metric**)
- F1-Score
- Confusion Matrix
- ROC-AUC

The final model achieved a **Recall above 90%**, significantly reducing false negatives, which is crucial for early Alzheimerâ€™s detection.

---

## ğŸ–¥ï¸ Graphical User Interface
An interactive **graphical user interface (GUI)** was developed using **Streamlit**, allowing users to:

- Input clinical patient data
- Obtain real-time predictions
- Visualize results in a clear and intuitive way

This transforms the model into an **accessible and user-friendly tool** for non-technical users.

---

## ğŸš€ Technologies Used
- Python
- Pandas, NumPy
- Scikit-learn
- XGBoost
- Matplotlib, Seaborn
- Streamlit
- Google Colab
- GitHub

---

## ğŸ“‚ Repository Structure

â”œâ”€â”€ notebooks/
â”‚ â””â”€â”€ Alzheimer_Analysis.ipynb
â”œâ”€â”€ app.py
â”œâ”€â”€ alzheimer_model.pkl
â”œâ”€â”€ requirements.txt
â””â”€â”€ README.md


---

## âš ï¸ Ethical Considerations
- The project uses **public and anonymized data**
- The model **does not replace medical diagnosis**
- Its use is strictly educational and supportive
- Predictions must be interpreted by healthcare professionals

---

## ğŸ‘¥ Authors
- **Santiago SantamarÃ­a**
- **Emanuel**

Academic project â€” Machine Learning applied to healthcare ğŸ§ 

---

## ğŸ“Œ Conclusion
This project demonstrates how Machine Learning can provide valuable support in high-impact social problems such as Alzheimerâ€™s disease, while maintaining a responsible, interpretable, and clinically relevant approach.
